Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 6.21 is 133% above its 5-year average of 2.67, around the middle of its 5-year range (0.68–10.02).
As of the fiscal period ended Tuesday, June 30, 2026. 2.86% below its 12-month average of 6.40.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 6.21.
CURRENT RATIO
6.21
CURRENT RATIO AVG TTM
6.40
CURRENT RATIO AVG 3Y
3.57
CURRENT RATIO AVG 5Y
2.67
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-2.86%
CURRENT VS 3Y AVG
+74.30%
CURRENT VS 5Y AVG
+132.81%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.59
median of 760 covered companies
CURRENT VS SECTOR MEDIAN
+72.85%
vs the sector median at left
Revelation Biosciences, Inc.
Market Cap
$3.12M
Current Ratio
6.21
TTM Avg
6.40
3Y Avg
3.57
5Y Avg
2.67
Market Cap
$3.07M
Current Ratio
2.35
TTM Avg
1.91
3Y Avg
2.68
5Y Avg
12.13
Market Cap
$2.99M
Current Ratio
1.41
TTM Avg
2.85
3Y Avg
1.58
5Y Avg
2.33
Market Cap
$3.25M
Current Ratio
8.18
TTM Avg
4.65
3Y Avg
2.72
5Y Avg
3.39
Market Cap
$3.35M
Current Ratio
3.73
TTM Avg
3.25
3Y Avg
4.33
5Y Avg
4.33
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Revelation Biosciences, Inc. (REVB) | $3.12M | 6.21 | 6.40 | 3.57 | 2.67 |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.07M | 2.35 | 1.91 | 2.68 | 12.13 |
| MBody AI Ltd. (MBAI)vs › | $3.17M | 0.05 | 0.10 | 7.85 | 8.89 |
| IceCure Medical Ltd (ICCM)vs › | $3.20M | 2.87 | 2.28 | 3.68 | 4.14 |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $2.99M | 1.41 | 2.85 | 1.58 | 2.33 |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.25M | 8.18 | 4.65 | 2.72 | 3.39 |
| Aethlon Medical, Inc. (AEMD)vs › | $3.29M | 5.42 | 3.49 | 5.10 | 6.32 |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.35M | 3.73 | 3.25 | 4.33 | 4.33 |
| Moolec Science S.A. (MLEC)vs › | $3.37M | 0.15 | 0.91 | 0.63 | 0.64 |
| Eocene Ltd. (EOCN)vs › | $3.46M | N/A | N/A | N/A | N/A |
Current Ratio
6.21
Quick Ratio
6.21
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 6.21 |
| 2026-03-31 | 10.02 |
| 2025-12-31 | 5.41 |
| 2025-09-30 | 6.92 |
| 2025-06-30 | 3.42 |
| 2025-03-31 | 3.61 |
| 2024-12-31 | 3.43 |
| 2024-09-30 | 1.64 |
| 2024-06-30 | 1.10 |
| 2024-03-31 | 2.80 |
| 2023-12-31 | 2.18 |
| 2023-09-30 | 2.62 |
| 2023-06-30 | 3.45 |
| 2023-03-31 | 2.23 |
| 2022-12-31 | 1.21 |
| 2022-09-30 | 1.49 |
| 2022-06-30 | 0.68 |
| 2022-03-31 | 0.97 |
| 2021-12-31 | 0.89 |
| 2021-09-30 | 2.58 |
| 2021-06-30 | 4.81 |
| 2021-03-31 | 0.24 |
| 2020-12-31 | 0.19 |
| 2020-09-30 | 9.88 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 0.00 |
